Skip to content
10-Q

Quarterly Report

Genprex, Inc. GNPX

0001437749-26-016755

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 10.59M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.14M
Operating Cash Flow restated Q1 2026 · Mar 31, 2025 −$4.16M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $18.05M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $7.83M
Stockholders Equity Q1 2026 · Mar 31, 2026 $16.93M
Stockholders Equity Q1 2026 · Dec 31, 2025 $7.96M
Stockholders Equity Q1 2026 · Mar 31, 2025 $3.87M
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.62M
Current Liabilities Q1 2026 · Mar 31, 2026 $3.35M
Current Liabilities Q1 2026 · Dec 31, 2025 $2.17M
Total Liabilities Q1 2026 · Mar 31, 2026 $3.38M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.2M
Current Assets Q1 2026 · Mar 31, 2026 $18.8M
Current Assets Q1 2026 · Dec 31, 2025 $8.36M
Total Assets Q1 2026 · Mar 31, 2026 $20.31M
Total Assets Q1 2026 · Dec 31, 2025 $10.16M
Eps Basic Q1 2026 · Mar 31, 2026 −$0.64
Eps Basic restated Q1 2026 · Mar 31, 2025 −$12.98
Sga Expense Q1 2026 · Mar 31, 2026 $1.75M
Sga Expense Q1 2026 · Mar 31, 2025 $1.43M
Rd Expense Q1 2026 · Mar 31, 2026 $2.75M
Rd Expense Q1 2026 · Mar 31, 2025 $2.54M
Net Income Q1 2026 · Mar 31, 2026 −$4.46M
Net Income Q1 2026 · Mar 31, 2025 −$3.96M
Operating Income Q1 2026 · Mar 31, 2026 −$4.49M
Operating Income Q1 2026 · Mar 31, 2025 −$3.97M